CONTEXT: Emerging evidence suggests that vitamin D and PTH may play a role in the development of cardiac diseases. OBJECTIVE: We investigated whether 25-hydroxyvitamin D (25OHD) and PTH concentrations are cross-sectionally associated with cardiac structure and function using magnetic resonance imaging (MRI). DESIGN, SETTING, AND PARTICIPANTS: ICELAND-MI is a substudy of the Age, Gene/Environment Susceptibility-Reykjavik Study, an older-aged community-dwelling cohort with oversampling of participants with diabetes (29%) and measurements between 2004 and 2007. Serum 25OHD concentrations were measured using an immunoassay (n = 992). Intact PTH concentrations were measured using a 2-site immunoassay (n = 203). We included 969 participants for this cross-sectional analysis (mean age 76 ± 5.3 years, 51% female). Mean 25OHD was 54.2 ± 25.5 nmol/L and the median PTH was 4.5 pmol/L (range 1.5-18). MAIN OUTCOMES: MRI to measure cardiac structure and function was the main outcome. RESULTS: The lowest 25OHD category (<25 nmol/L) compared with the highest category (≥75 nmol/L) was associated with a smaller left and right atrial area in unadjusted analyses; however, the associations became nonsignificant after adjustment for covariates. The highest PTH quartile compared with the lowest quartile was significantly associated with a 7.3 g (95% confidence interval 0.8, 13.8) greater left ventricular (LV) mass and a 5.1% (-9.1, -1.1) lower LV ejection fraction compared with the lowest PTH quartile in the fully adjusted model. CONCLUSIONS: Serum 25OHD concentrations were not associated with MRI measures in an older white population. Higher PTH concentrations were associated with greater LV mass and lower systolic function and may point to a potential role for PTH as a determinant of cardiac remodeling.
CONTEXT: Emerging evidence suggests that vitamin D and PTH may play a role in the development of cardiac diseases. OBJECTIVE: We investigated whether 25-hydroxyvitamin D (25OHD) and PTH concentrations are cross-sectionally associated with cardiac structure and function using magnetic resonance imaging (MRI). DESIGN, SETTING, AND PARTICIPANTS: ICELAND-MI is a substudy of the Age, Gene/Environment Susceptibility-Reykjavik Study, an older-aged community-dwelling cohort with oversampling of participants with diabetes (29%) and measurements between 2004 and 2007. Serum 25OHD concentrations were measured using an immunoassay (n = 992). Intact PTH concentrations were measured using a 2-site immunoassay (n = 203). We included 969 participants for this cross-sectional analysis (mean age 76 ± 5.3 years, 51% female). Mean 25OHD was 54.2 ± 25.5 nmol/L and the median PTH was 4.5 pmol/L (range 1.5-18). MAIN OUTCOMES: MRI to measure cardiac structure and function was the main outcome. RESULTS: The lowest 25OHD category (<25 nmol/L) compared with the highest category (≥75 nmol/L) was associated with a smaller left and right atrial area in unadjusted analyses; however, the associations became nonsignificant after adjustment for covariates. The highest PTH quartile compared with the lowest quartile was significantly associated with a 7.3 g (95% confidence interval 0.8, 13.8) greater left ventricular (LV) mass and a 5.1% (-9.1, -1.1) lower LV ejection fraction compared with the lowest PTH quartile in the fully adjusted model. CONCLUSIONS: Serum 25OHD concentrations were not associated with MRI measures in an older white population. Higher PTH concentrations were associated with greater LV mass and lower systolic function and may point to a potential role for PTH as a determinant of cardiac remodeling.
Authors: Stefan Pilz; Andreas Tomaschitz; Christiane Drechsler; Eberhard Ritz; Bernhard O Boehm; Tanja B Grammer; Winfried März Journal: Eur Heart J Date: 2010-05-02 Impact factor: 29.983
Authors: Margret Leosdottir; Ronnie Willenheimer; Jonathan Plehn; Rasmus Borgquist; Petri Gudmundsson; Tamara B Harris; Lenore J Launer; Halldora Bjornsdottir; Peter M Nilsson; Vilmundur Gudnason Journal: Am Heart J Date: 2010-03 Impact factor: 4.749
Authors: Igor Klem; Dipan J Shah; Richard D White; Dudley J Pennell; Albert C van Rossum; Matthias Regenfus; Udo Sechtem; Paulo R Schvartzman; Peter Hunold; Pierre Croisille; Michele Parker; Robert M Judd; Raymond J Kim Journal: Circ Cardiovasc Imaging Date: 2011-09-12 Impact factor: 7.792
Authors: M D Walker; J B Fleischer; M R Di Tullio; S Homma; T Rundek; E M Stein; C Zhang; T Taggart; D J McMahon; S J Silverberg Journal: J Clin Endocrinol Metab Date: 2010-03-12 Impact factor: 5.958
Authors: P Ameri; M Canepa; Y Milaneschi; P Spallarossa; G Leoncini; F Giallauria; J B Strait; E G Lakatta; C Brunelli; G Murialdo; L Ferrucci Journal: J Intern Med Date: 2012-11-12 Impact factor: 8.989
Authors: Emil Hagström; Per Hellman; Tobias E Larsson; Erik Ingelsson; Lars Berglund; Johan Sundström; Håkan Melhus; Claes Held; Lars Lind; Karl Michaëlsson; Johan Arnlöv Journal: Circulation Date: 2009-05-18 Impact factor: 29.690
Authors: Stefan Pilz; Winfried März; Britta Wellnitz; Ursula Seelhorst; Astrid Fahrleitner-Pammer; Hans P Dimai; Bernhard O Boehm; Harald Dobnig Journal: J Clin Endocrinol Metab Date: 2008-08-05 Impact factor: 5.958
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Á Aceña; A M Pello; R Carda; Ó Lorenzo; M L Gonzalez-Casaus; L M Blanco-Colio; J L Martín-Ventura; J Palfy; M Orejas; R Rábago; E Gonzalez-Parra; I Mahíllo-Fernández; J Farré; J Egido; J Tuñón Journal: J Nutr Health Aging Date: 2016 Impact factor: 4.075
Authors: Michael P Dorsch; Carrie W Nemerovski; Vicki L Ellingrod; Jennifer A Cowger; D Bradley Dyke; Todd M Koelling; Audrey H Wu; Keith D Aaronson; Robert U Simpson; Barry E Bleske Journal: J Cardiovasc Pharmacol Ther Date: 2014-02-04 Impact factor: 2.457
Authors: Stefan Pilz; Nicolas Verheyen; Martin R Grübler; Andreas Tomaschitz; Winfried März Journal: Nat Rev Cardiol Date: 2016-05-06 Impact factor: 32.419
Authors: Anand Vaidya; Gary C Curhan; Julie M Paik; Henry Kronenberg; Eric N Taylor Journal: J Clin Endocrinol Metab Date: 2015-04-17 Impact factor: 5.958